Literature DB >> 30943076

Influence of Cigarette Smoking at the Time of Surgery on Postoperative Outcomes in Patients With Femoroacetabular Impingement: A Matched-Pair Cohort Analysis.

Jourdan Cancienne1, Kyle N Kunze1, Edward C Beck1, Jorge Chahla1, Sunikom Suppauksorn1, Shane J Nho1.   

Abstract

BACKGROUND: There is literature on the association between smoking in patients undergoing orthopaedic procedures and poor short-term outcomes. However, there are few data on smoking as an independent predictor of midterm outcomes in patients undergoing hip arthroscopic surgery for femoroacetabular impingement (FAI).
PURPOSE: To evaluate 2-year postoperative outcomes in patients undergoing hip arthroscopic surgery for FAI in current smokers compared with an age- and body mass index (BMI)-matched group with no smoking history. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: Consecutive patients undergoing primary hip arthroscopic surgery for FAI between June 2012 and January 2016 were screened for smoking habits. Exclusion criteria included revision or bilateral surgery, dysplasia, and less than 2-year follow-up. Forty current smokers at the time of surgery were matched 1:2 by age and BMI to patients with no smoking history. Outcome measures included the Hip Outcome Score (HOS)-Activities of Daily Living (ADL), HOS-Sports-Specific Subscale (SSS), modified Harris Hip Score (mHHS), and visual analog scale (VAS) for pain and satisfaction. Minimal clinically important difference (MCID) and patient acceptable symptom state rates were calculated for all patients.
RESULTS: All patients demonstrated significant improvements in all outcome measures ( P < .001). Current smokers experienced inferior postoperative HOS-ADL (80.4 vs 89.1, respectively; P = .013) and HOS-SSS (65.8 vs 75.6, respectively; P = .046) scores and greater VAS pain scores (3.2 vs 1.8, respectively; P = .011) than nonsmokers. Current smoking was correlated with inferior HOS-ADL ( r = -0.27, P = .003) and HOS-SSS ( r = -0.18, P = .046) scores and greater VAS pain scores ( r = 0.26, P = .005). Controlling for age, sex, and BMI, smoking was a significant independent predictor of postoperative HOS-ADL (β = -8.7 [95% CI, -14.3 to -3.0]; P = .003), HOS-SSS (β = -9.8 [95% CI, -19.5 to -0.2]; P = .046), and VAS pain (β = 14.6 [95% CI, 4.4 to 23.7]; P = .005) scores. Current smokers had lower odds of achieving the MCID for the HOS-ADL (odds ratio, 0.31 [95% CI, 0.12-0.83]; P = .019) and mHHS (odds ratio, 0.31 [95% CI, 0.10-0.88]; P = .028).
CONCLUSION: Current smokers had inferior postoperative HOS-ADL and HOS-SSS scores, increased pain, and lower odds of achieving the MCID for the HOS-ADL and mHHS at 2 years postoperatively than patients without any smoking history.

Entities:  

Keywords:  cigarette; femoroacetabular impingement; hip arthroscopic surgery; hip outcomes; smoking

Mesh:

Year:  2019        PMID: 30943076     DOI: 10.1177/0363546519832545

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  9 in total

Review 1.  A practical guide for perioperative smoking cessation.

Authors:  Hiroki Iida; Tetsuya Kai; Michioki Kuri; Kumiko Tanabe; Masashi Nakagawa; Chizuru Yamashita; Hiroshi Yonekura; Mami Iida; Ikuo Fukuda
Journal:  J Anesth       Date:  2022-08-01       Impact factor: 2.931

2.  Effect of Cigarette Smoking on Midterm Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: A Propensity-Matched Controlled Study With Minimum 5-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-05-10

3.  Comparison of Outcomes Between Nonsmokers and Patients Who Discontinued Smoking 1 Month Before Primary Hip Arthroscopy: A Propensity-Matched Study With Minimum 2-Year Follow-up.

Authors:  Michael S Lee; Andrew E Jimenez; Jade S Owens; Andrew J Curley; Olivia A Paraschos; David R Maldonado; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-06-08

4.  Development of Machine Learning Algorithms to Predict Being Lost to Follow-up After Hip Arthroscopy for Femoroacetabular Impingement Syndrome.

Authors:  Kyle N Kunze; Robert A Burnett; Elaine K Lee; Jonathan P Rasio; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-09-22

5.  Defining the Clinically Meaningful Outcomes for Arthroscopic Treatment of Femoroacetabular Impingement Syndrome at Minimum 10-Year Follow-up: The Timing of Surgery Is Crucial.

Authors:  Alexander Zimmerer; Viktor Janz; Christian Sobau; Georgi I Wassilew; Wolfgang Miehlke
Journal:  Orthop J Sports Med       Date:  2021-02-25

Review 6.  Evaluation of outcome reporting trends for femoroacetabular impingement syndrome- a systematic review.

Authors:  Ida Lindman; Sarantos Nikou; Axel Öhlin; Eric Hamrin Senorski; Olufemi Ayeni; Jon Karlsson; Mikael Sansone
Journal:  J Exp Orthop       Date:  2021-04-23

7.  Effect of Cigarette Smoking on Outcomes in Patients Undergoing Primary Hip Arthroscopy and Labral Reconstruction: A Propensity-Matched Controlled Study With Minimum 2-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Tom George; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-02-24

8.  Preoperative psychometric properties of visual analog scale asessments for function, pain, and strength compared with legacy upper extremity outcome measures in glenohumeral osteoarthritis.

Authors:  Alexander Beletsky; Yining Lu; Benedict U Nwachukwu; Evan Polce; Bhargavi Maheshwer; Jorge Chahla; Brian Forsythe; Brian J Cole; Nikhil N Verma
Journal:  JSES Int       Date:  2020-06-17

9.  Psychometric properties of visual analog scale assessments for function, pain, and strength compared with disease-specific upper extremity outcome measures in rotator cuff repair.

Authors:  Alexander Beletsky; Benedict U Nwachukwu; Tomás Gorodischer; Jorge Chahla; Brian Forsythe; Brian J Cole; Nikhil N Verma
Journal:  JSES Int       Date:  2020-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.